GlassScriptPhysician profile
Andrew J Binder
NPI 1578770707
$6,238.41
in general payments reported to CMS, 2019-2025
39 companies · $1,197 in 2025
The $1,197 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.53 · 2020: $241 · 2021: $1,122 · 2022: $1,352 · 2023: $1,462 · 2024: $845 · 2025: $1,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,504.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $846.69 | 2021-2025 | |
| Heartflow, INC. | $835.78 | 2020-2023 | Ffrct |
| Novo Nordisk INC | $504.35 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $480.73 | 2020-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $432.26 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $419.45 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $263.36 | 2021-2023 | Xarelto |
| Esperion Therapeutics, INC. | $224.88 | 2021-2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $215.14 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $180.50 | 2021-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.96 | 2021-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $145.09 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.76 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $125.65 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.44 | 2021-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $100.51 | 2023-2025 | Extended Holter |
| Boston Scientific Corporation | $100.32 | 2023 | Watchman Access System |
| Inspire Medical Systems, INC. | $99.77 | 2023-2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $86.30 | 2023-2025 | Onpattro, Amvuttra |
| Amarin Pharma, INC. | $79.27 | 2021-2023 | |
| Medtronic, INC. | $75.42 | 2025 | Linq II, Corevalve Evolut R |
| Siemens Medical Solutions USA, INC. | $63.60 | 2022-2025 | Somatom Pro.Pulse |
| Impulse Dynamics (USA) INC. | $61.61 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $58.69 | 2021-2023 | Arcalyst |
| Itamar Medical INC | $53.09 | 2022-2025 | Watchpatone |
| Bridgebio Pharma, INC. | $49.55 | 2025 | Attruby |
| Teleflex LLC | $49.53 | 2023 | Urolift |
| Cleerly, INC. | $40.54 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Cvrx, INC. | $37.61 | 2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $34.98 | 2023-2024 | |
| Glaxosmithkline, LLC. | $26.06 | 2025 | Arexvy |
| Lexicon Pharmaceuticals, INC. | $21.78 | 2023 | Inpefa |
| Ge Healthcare | $21.39 | 2021 | |
| Astellas Pharma US INC | $19.83 | 2021 | |
| Tactile Systems Technology INC | $13.89 | 2022 | |
| Althera Pharmaceuticals LLC | $12.93 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.73 | 2020 | |
| Lundbeck LLC | $12.57 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.